Iovance Biotherapeutics I... (IOVA)
3.26
0.05 (1.56%)
At close: Apr 23, 2025, 9:56 AM
Iovance Biotherapeutics Analyst Ratings
Total Analysts
9
Consensus Rating
Buy
Price Target
17
Upside
421.49
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Upside | Date |
| Goldman Sachs | Buy | Maintains | 18 16 | 390.81% | Apr 17, 2025 | |
| Barclays | Buy | Maintains | 22 5 | 53.38% | Apr 14, 2025 | |
| Truist Securities | Buy | Maintains | 25 15 | 360.14% | Mar 3, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.